FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048480161> ?p ?o ?g. }

• W2048480161 endingPage "431" @default.
• W2048480161 startingPage "419" @default.
• W2048480161 abstract "Despite the increase in the substitution of branded medicinal product with generic drugs, this is a controversial issue for some pharmacological groups (such as contraceptives).The aim of the present clinical trial was to assess the bioequivalence and tolerability of two oral formulations of desogestrel.Thirty-three healthy female volunteers participated in this randomized and two-way crossover study. During two separate experimental periods, with at least four weeks of washout period, women received a single oral dose of 75 μg of desogestrel from each of the formulations (test formulation and reference formulation). Desogestrel bioavailability was determined by the measurement of 3-ketodesogestrel plasma concentration.Pharmacokinetic parameters were comparable and the 90% CI for the ratio of Cmax (96.14–114.53%) and AUC0–t (105.73–123.83%) values for the test and reference formulations fell within the established regulatory interval (80–125%). Both formulations were also comparable in terms of tolerability.From the results of this study it can be concluded that test formulation (desogestrel 75 μg, Cyndea PHARMA S.L.) is bioequivalent to the reference formulation (Cerazet® 75 μg, Organon Española S.A.)." @default.
• W2048480161 created "2016-06-24" @default.
• W2048480161 creator A5003611839 @default.
• W2048480161 creator A5010487907 @default.
• W2048480161 creator A5053550221 @default.
• W2048480161 creator A5063498471 @default.
• W2048480161 creator A5065746345 @default.
• W2048480161 creator A5079476192 @default.
• W2048480161 creator A5079786709 @default.
• W2048480161 creator A5080567285 @default.
• W2048480161 creator A5046023449 @default.
• W2048480161 date "2012-01-01" @default.
• W2048480161 modified "2023-09-27" @default.
• W2048480161 title "Randomized, Crossover and Single-Dose Bioequivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 µg) in Healthy Female Volunteers" @default.
• W2048480161 cites W1546872120 @default.
• W2048480161 cites W1972673994 @default.
• W2048480161 cites W1974013474 @default.
• W2048480161 cites W1987420224 @default.
• W2048480161 cites W2004361944 @default.
• W2048480161 cites W2006031173 @default.
• W2048480161 cites W2050558447 @default.
• W2048480161 cites W2054160755 @default.
• W2048480161 cites W2072620734 @default.
• W2048480161 cites W2089597425 @default.
• W2048480161 cites W2092326070 @default.
• W2048480161 cites W2094894473 @default.
• W2048480161 cites W2096784005 @default.
• W2048480161 cites W2100560126 @default.
• W2048480161 cites W2111709107 @default.
• W2048480161 cites W2150150420 @default.
• W2048480161 cites W2165003772 @default.
• W2048480161 cites W2167901819 @default.
• W2048480161 cites W2418883539 @default.
• W2048480161 doi "https://doi.org/10.3797/scipharm.1111-18" @default.
• W2048480161 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3383212" @default.
• W2048480161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22896827" @default.
• W2048480161 hasPublicationYear "2012" @default.
• W2048480161 type Work @default.
• W2048480161 sameAs 2048480161 @default.
• W2048480161 citedByCount "6" @default.
• W2048480161 countsByYear W20484801612013 @default.
• W2048480161 countsByYear W20484801612017 @default.
• W2048480161 countsByYear W20484801612018 @default.
• W2048480161 countsByYear W20484801612019 @default.
• W2048480161 crossrefType "journal-article" @default.
• W2048480161 hasAuthorship W2048480161A5003611839 @default.
• W2048480161 hasAuthorship W2048480161A5010487907 @default.
• W2048480161 hasAuthorship W2048480161A5046023449 @default.
• W2048480161 hasAuthorship W2048480161A5053550221 @default.
• W2048480161 hasAuthorship W2048480161A5063498471 @default.
• W2048480161 hasAuthorship W2048480161A5065746345 @default.
• W2048480161 hasAuthorship W2048480161A5079476192 @default.
• W2048480161 hasAuthorship W2048480161A5079786709 @default.
• W2048480161 hasAuthorship W2048480161A5080567285 @default.
• W2048480161 hasBestOaLocation W20484801611 @default.
• W2048480161 hasConcept C112705442 @default.
• W2048480161 hasConcept C126322002 @default.
• W2048480161 hasConcept C142724271 @default.
• W2048480161 hasConcept C168563851 @default.
• W2048480161 hasConcept C181389837 @default.
• W2048480161 hasConcept C197934379 @default.
• W2048480161 hasConcept C204787440 @default.
• W2048480161 hasConcept C22979827 @default.
• W2048480161 hasConcept C27081682 @default.
• W2048480161 hasConcept C2778375690 @default.
• W2048480161 hasConcept C2779076696 @default.
• W2048480161 hasConcept C2779441745 @default.
• W2048480161 hasConcept C2908647359 @default.
• W2048480161 hasConcept C2986817661 @default.
• W2048480161 hasConcept C42404028 @default.
• W2048480161 hasConcept C71924100 @default.
• W2048480161 hasConcept C87813604 @default.
• W2048480161 hasConcept C98274493 @default.
• W2048480161 hasConcept C99454951 @default.
• W2048480161 hasConceptScore W2048480161C112705442 @default.
• W2048480161 hasConceptScore W2048480161C126322002 @default.
• W2048480161 hasConceptScore W2048480161C142724271 @default.
• W2048480161 hasConceptScore W2048480161C168563851 @default.
• W2048480161 hasConceptScore W2048480161C181389837 @default.
• W2048480161 hasConceptScore W2048480161C197934379 @default.
• W2048480161 hasConceptScore W2048480161C204787440 @default.
• W2048480161 hasConceptScore W2048480161C22979827 @default.
• W2048480161 hasConceptScore W2048480161C27081682 @default.
• W2048480161 hasConceptScore W2048480161C2778375690 @default.
• W2048480161 hasConceptScore W2048480161C2779076696 @default.
• W2048480161 hasConceptScore W2048480161C2779441745 @default.
• W2048480161 hasConceptScore W2048480161C2908647359 @default.
• W2048480161 hasConceptScore W2048480161C2986817661 @default.
• W2048480161 hasConceptScore W2048480161C42404028 @default.
• W2048480161 hasConceptScore W2048480161C71924100 @default.
• W2048480161 hasConceptScore W2048480161C87813604 @default.
• W2048480161 hasConceptScore W2048480161C98274493 @default.
• W2048480161 hasConceptScore W2048480161C99454951 @default.
• W2048480161 hasIssue "2" @default.
• W2048480161 hasLocation W20484801611 @default.
• W2048480161 hasLocation W20484801612 @default.
• W2048480161 hasLocation W20484801613 @default.
• W2048480161 hasOpenAccess W2048480161 @default.

• next